Below are selected clips of national and international press coverage of ATS advocacy efforts, research published in ATS journals and research presented at the American Thoracic Society International Conference.
Medpage Today (May 20, 2024) Once Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial [ATS 2024]
Reuters (May 19, 2024) U.S. Race-Neutral Lung Assessments to Have Profound Effects, Study Finds [ATS 2024]
STAT (May 19, 2024) Removing Race Adjustment from Lung Test Could Mean Higher Disability Payments for Black Vets [Nirav Bhakta, ATS 2024]
Managed Healthcare Executive (May 18, 2024) Dr. Glaucomflecen the Opening Speaker at the 2024 ATS Meeting
Managed Healthcare Executive (May 18, 2024) AI on the Agenda at 2024 ATS, Says Conference Chair [Debra Boyer, MD]
American Journal of Managed Care (May 16, 2024) Dr. Debra Boyer Previews ATS 2024 International Conference
(May 14, 2024) Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference | Gossamer Bio
Business Wire (May 6, 2024) Vasomune Therapeutics Announces Poster Presentation at the American Thoracic Society International Conference
Business Wire (May 1, 2024) Endeavor BioMedicines to Present New Data from Phase 2a Clinical Trial of ENV-101 at American Thoracic Society 2024 International Conference
NPR (March 29, 2024) EPA's New Rules to Clean up Heavy Trucking Met with Support and Criticism [Dr. Franziska Rosser]
Fox 5 San Diego (March 29, 2024) How do Rainstorms Affect San Diego's Air Quality? [Health of the Air Report]